| Imaging plays a central role in the healthcare sECTOR Recent market studies have shown that nearly 80% of medical acts rely on images. There are two types of imaging: "in vivo", a quick and accurate non-invasive way of observing anatomical structures (structural imaging) and dynamic phenomena (functional imaging); and “in vitro”, used to describe changes in biological tissues, cells or genes using biological samples (microscopic imaging). Medical imaging utilizes all image formation methods and techniques (photon, magnetic fields, radiation, X-ray or ultrasound) which may be combined within a single system (multimodal imaging). The images can be used for display only, for instance for 3-D reconstruction of a region of interest, or for quantification purposes such as the measurement of biological parameters. Medical imaging is also closely linked to information storage technologies such as PACS, DPM, DICOM; to robotics for positioning image sensors, surgical instruments or even ionizing sources (medical robotics); and to telecommunications in the realm of telemedicine. |
5 strategic axes
Magellium is currently focusing on the five following healthcare and biotechnology applications:
• Multimodal imaging
• Image based eLearning
• Video-microscopy
• Robotics
• GIS and telemedicine applications
Collaborative projects
Magellium is already engaged in a number of collaborative projects:
Magellium is leading the CAMM4D onco-dermatology project which is being conducted in conjunction with the Pierre Fabre research institute (IRPF/CRP/I2C), the department of onco-dermatology of the Toulouse University Hospital (CHU) and the IRIT-ENSEEITH laboratory. The project has been recognised by the Cancer-Bio-Health cluster in November 2007 and was listed for a national grant (DGE) in March 2008.
Skin cancers have doubled in the past twenty years to become a major public health concern. Melanomas generally display biphasic growth patterns characterized by horizontal (intra-dermal) and vertical (sub-dermal) growth. The diagnosis and prognosis of melanoma is currently impossible “in vivo”. This biphasic growth pattern is particularly suited to the use of complementary, multimodal imaging systems combining:
Magellium is taking part, with the support of InNaBioSanté, in the Nanomultiplex project awarded by the ITAV institute in partnership with IPBS and LAAS laboratories. The idea behind the project is to use soft micro-lithography to position individual molecules of DNA on a glass dish and to use video-microscopy to monitor 2D movements (TPM - Tethered Particle Motion) of a bead attached to the bio molecule to observe the genetic recombining process. Magellium is working on the low-light image acquisition microscope and the real-time probe detection and movement characterization algorithms.
e-HEMATImage is an ongoing education program for professionals working in clinical biology laboratories. The purpose of the platform is to share microscopic imagery of real-case blood smears during web-based haematology training sessions.
The platform, which is available in eight European languages is the culmination of ten years’ work with Professor Corberand’s team at the FCBM foundation. The platform is based on the MedecinIm@ge training program, currently used by more than 2000 laboratories in 16 French-speaking countries worldwide and which covers the fields of haematology, mycology, cytology and parasitology.
Magellium is leading the CAMM4D onco-dermatology project which is being conducted in conjunction with the Pierre Fabre research institute (IRPF/CRP/I2C), the department of onco-dermatology of the Toulouse University Hospital (CHU) and the IRIT-ENSEEITH laboratory. The project has been recognised by the Cancer-Bio-Health cluster in November 2007 and was listed for a national grant (DGE) in March 2008.
Skin cancers have doubled in the past twenty years to become a major public health concern. Melanomas generally display biphasic growth patterns characterized by horizontal (intra-dermal) and vertical (sub-dermal) growth. The diagnosis and prognosis of melanoma is currently impossible “in vivo”. This biphasic growth pattern is particularly suited to the use of complementary, multimodal imaging systems combining:
• video-dermascopy for the surface of the skinThe initial purpose of the project is to provide clinicians with a multimodal imaging platform for the early detection and monitoring of melanomas combining the advanced image acquisition technologies cited above. The method could be extended to tele-dermatology at a later stage.
• high-frequency ultrasound (20 and 50MHz) for the dermis
• optical coherence tomography (OCT) for the epidermis
Magellium is taking part, with the support of InNaBioSanté, in the Nanomultiplex project awarded by the ITAV institute in partnership with IPBS and LAAS laboratories. The idea behind the project is to use soft micro-lithography to position individual molecules of DNA on a glass dish and to use video-microscopy to monitor 2D movements (TPM - Tethered Particle Motion) of a bead attached to the bio molecule to observe the genetic recombining process. Magellium is working on the low-light image acquisition microscope and the real-time probe detection and movement characterization algorithms.
e-HEMATImage is an ongoing education program for professionals working in clinical biology laboratories. The purpose of the platform is to share microscopic imagery of real-case blood smears during web-based haematology training sessions.
The platform, which is available in eight European languages is the culmination of ten years’ work with Professor Corberand’s team at the FCBM foundation. The platform is based on the MedecinIm@ge training program, currently used by more than 2000 laboratories in 16 French-speaking countries worldwide and which covers the fields of haematology, mycology, cytology and parasitology.